Charles Schwab’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.7M Sell
197,620
-5,560
-3% -$1.34M 0.01% 1140
2025
Q1
$49.5M Buy
203,180
+11,313
+6% +$2.76M 0.01% 1078
2024
Q4
$63M Buy
191,867
+7,552
+4% +$2.48M 0.01% 961
2024
Q3
$61.7M Sell
184,315
-46,341
-20% -$15.5M 0.01% 966
2024
Q2
$63M Buy
230,656
+7,215
+3% +$1.97M 0.01% 903
2024
Q1
$77.3M Buy
223,441
+9,207
+4% +$3.18M 0.02% 739
2023
Q4
$69.2M Buy
214,234
+10,040
+5% +$3.24M 0.02% 760
2023
Q3
$73.2M Buy
204,194
+2,645
+1% +$948K 0.02% 652
2023
Q2
$76.4M Buy
201,549
+1,133
+0.6% +$430K 0.02% 625
2023
Q1
$96M Buy
200,416
+4,526
+2% +$2.17M 0.03% 516
2022
Q4
$82.4M Buy
195,890
+11,543
+6% +$4.85M 0.03% 557
2022
Q3
$76.9M Buy
184,347
+3,824
+2% +$1.6M 0.03% 538
2022
Q2
$89.4M Buy
180,523
+6,597
+4% +$3.27M 0.03% 498
2022
Q1
$98M Buy
173,926
+5,416
+3% +$3.05M 0.03% 522
2021
Q4
$127M Buy
168,510
+4,735
+3% +$3.58M 0.04% 433
2021
Q3
$122M Buy
163,775
+5,024
+3% +$3.75M 0.04% 411
2021
Q2
$102M Buy
158,751
+4,227
+3% +$2.72M 0.03% 480
2021
Q1
$88.3M Buy
154,524
+415
+0.3% +$237K 0.03% 511
2020
Q4
$89.8M Sell
154,109
-4,063
-3% -$2.37M 0.04% 457
2020
Q3
$81.5M Buy
158,172
+2,144
+1% +$1.11M 0.04% 420
2020
Q2
$70.4M Buy
156,028
+27,911
+22% +$12.6M 0.03% 480
2020
Q1
$44.9M Buy
128,117
+1,935
+2% +$678K 0.03% 570
2019
Q4
$46.7M Buy
126,182
+673
+0.5% +$249K 0.03% 668
2019
Q3
$41.8M Buy
125,509
+10,616
+9% +$3.53M 0.02% 681
2019
Q2
$35.9M Buy
114,893
+820
+0.7% +$256K 0.02% 757
2019
Q1
$34.9M Buy
114,073
+7,945
+7% +$2.43M 0.02% 750
2018
Q4
$24.6M Buy
106,128
+1,642
+2% +$381K 0.02% 851
2018
Q3
$32.7M Sell
104,486
-30,361
-23% -$9.5M 0.02% 789
2018
Q2
$38.9M Buy
134,847
+6,460
+5% +$1.86M 0.03% 622
2018
Q1
$32.1M Buy
128,387
+5,533
+5% +$1.38M 0.03% 698
2017
Q4
$29.3M Buy
122,854
+4,332
+4% +$1.03M 0.02% 718
2017
Q3
$26.3M Buy
118,522
+3,304
+3% +$734K 0.02% 715
2017
Q2
$26.1M Buy
115,218
+2,070
+2% +$468K 0.02% 679
2017
Q1
$22.6M Buy
113,148
+9,164
+9% +$1.83M 0.02% 750
2016
Q4
$19M Buy
103,984
+6,918
+7% +$1.26M 0.02% 787
2016
Q3
$15.9M Buy
97,066
+9,162
+10% +$1.5M 0.02% 832
2016
Q2
$12.6M Buy
87,904
+2,559
+3% +$366K 0.02% 915
2016
Q1
$11.7M Buy
85,345
+5,188
+6% +$709K 0.02% 941
2015
Q4
$11.1M Sell
80,157
-1,157
-1% -$160K 0.02% 945
2015
Q3
$10.9M Buy
81,314
+5,291
+7% +$711K 0.02% 936
2015
Q2
$11.5M Sell
76,023
-59,151
-44% -$8.91M 0.02% 924
2015
Q1
$18.3M Sell
135,174
-19,176
-12% -$2.59M 0.03% 602
2014
Q4
$18.6M Sell
154,350
-9,600
-6% -$1.16M 0.03% 545
2014
Q3
$18.6M Buy
163,950
+9,726
+6% +$1.1M 0.03% 517
2014
Q2
$18.5M Buy
154,224
+1,457
+1% +$174K 0.03% 511
2014
Q1
$19.6M Buy
152,767
+14,943
+11% +$1.91M 0.04% 471
2013
Q4
$17M Buy
137,824
+4,821
+4% +$596K 0.03% 484
2013
Q3
$15.8M Buy
133,003
+21,846
+20% +$2.6M 0.03% 468
2013
Q2
$12.6M Buy
+111,157
New +$12.6M 0.03% 498